How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Authors
Keywords
-
Journal
Journal of Atherosclerosis and Thrombosis
Volume -, Issue -, Pages -
Publisher
Japan Atherosclerosis Society
Online
2022-01-13
DOI
10.5551/jat.rv17063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
- (2021) Takahito Doi et al. Journal of the American Heart Association
- Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
- (2021) Paul M Ridker et al. CIRCULATION RESEARCH
- Suboptimal lipoprotein (a) control and residual plaque instability despite proprotein convertase subtilisin/kexin type 9 inhibitor use in heterozygous familial hypercholesterolaemia: insights from serial near-infrared spectroscopy imaging
- (2021) Kazumasa Imamoto et al. EUROPEAN HEART JOURNAL
- Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
- (2021) Laura D’Erasmo et al. Journal of the American Heart Association
- Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia
- (2021) Martine Paquette et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
- (2021) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study
- (2021) Masatsune Ogura et al. Journal of Atherosclerosis and Thrombosis
- Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene
- (2021) Hayato Tada et al. Journal of Atherosclerosis and Thrombosis
- Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
- (2021) Ryo Naito et al. Journal of Atherosclerosis and Thrombosis
- Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J
- (2021) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Targeting cardiovascular inflammation: next steps in clinical translation
- (2020) Patrick R Lawler et al. EUROPEAN HEART JOURNAL
- Framingham General Cardiovascular Risk Score and Cognitive Impairment
- (2020) Costantino Iadecola et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia
- (2020) Leopoldo Pérez de Isla et al. EUROPEAN HEART JOURNAL
- Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction
- (2019) Amit V. Khera et al. CIRCULATION
- Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
- (2019) Katrina L. Ellis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia
- (2019) Ye-Xuan Cao et al. ATHEROSCLEROSIS
- Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease
- (2018) David Chieng et al. Journal of Clinical Lipidology
- Translating Evidence of HDL and Plaque Regression
- (2018) Belinda A. Di Bartolo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
- (2018) Amy W. Zawacki et al. Journal of Clinical Lipidology
- Clinical Genetic Testing for Familial Hypercholesterolemia
- (2018) Amy C. Sturm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
- (2018) Steve E. Humphries et al. ATHEROSCLEROSIS
- Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia
- (2017) Yu Kataoka et al. Journal of Clinical Lipidology
- Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE
- (2017) Martine Paquette et al. Journal of Clinical Lipidology
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia
- (2016) Rodrigo Alonso et al. ATHEROSCLEROSIS
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE
- (2016) Karin Leander et al. CIRCULATION
- Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia
- (2016) Naotaka Ohta et al. Journal of Clinical Lipidology
- Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease
- (2016) Barbara Sjouke et al. Journal of Clinical Lipidology
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
- (2016) Anne Langsted et al. Lancet Diabetes & Endocrinology
- Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia
- (2015) Masatsune Ogura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary PreventionSignificance
- (2015) Yiming M. Zhu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- Prognostic value of PCSK9 levels in patients with acute coronary syndromes
- (2015) Baris Gencer et al. EUROPEAN HEART JOURNAL
- PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
- (2015) Yuichi J. Shimada et al. EUROPEAN HEART JOURNAL
- Removal of Plasma Mature and Furin-Cleaved Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein-Apheresis in Familial Hypercholesterolemia: Development and Application of a New Assay for PCSK9
- (2015) Mika Hori et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Isolation and characterization of the circulating truncated form of PCSK9
- (2014) Bomie Han et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein(a) Levels in Familial Hypercholesterolemia
- (2014) Rodrigo Alonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Severe Hypercholesterolemia Phenotype
- (2014) Allan D. Sniderman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. CIRCULATION
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
- (2011) Natacha Bellanger et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
- (2011) Lisan A. Neefjes et al. ATHEROSCLEROSIS
- Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- (2011) Paul N. Hopkins et al. Journal of Clinical Lipidology
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- In VivoEvidence That Furin from Hepatocytes Inactivates PCSK9
- (2010) Rachid Essalmani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
- (2010) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started